A major study involving over 160,000 dementia patients has found that risperidone, a commonly prescribed antipsychotic drug, is associated with higher stroke risk across all dementia patient groups ...

There is currently no cure for dementia, which afflicts an estimated 57 million people globally, and affects hundreds of millions more who are the family, friends, and caretakers of people with ...

We’ve spent billions chasing a dementia cure, only to hit one dead end after another. However, sometimes progress comes from ...

Glimmer of hope emerges in pilot trial of people with mild cognitive impairment ...

Alzheimer’s disease is one of humanity’s most formidable foes. It affects 10 percent of people over age 65 and kills more people each year than breast cancer and prostate cancer combined. Its effects ...

A bill making its way through the Nebraska Legislature would require state-regulated health plans to cover US Food and Drug Administration-approved dementia treatments and diagnostics as well as ...

Memory loss might have met its match. A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing ...

More than $100 million in federal funding was spent last year toward searching for a cure for Alzheimer's disease. However, if given the choice, most people with dementia and those caring for them ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

An updated systematic review of dozens of studies finds that Ginkgo biloba may offer modest short-term improvements for people with dementia, but shows little to no benefit for individuals with ...

A terrible irony of dementia — which can result in the inability to recognize people and places — is that the condition itself does not get the worldwide recognition it deserves. Until now. The United ...